Director Avi Kerendian's vision to help underserved people in the most disadvantaged areas of Latin America, thanks to the support of young professionals in the health sector, who are willing to create sustainable change in these places.
Although the current situation with the COVID-19 pandemic has led to the suspension of travel for the time being, the vision continues. For this reason, the GGHTX program has partnered with Dentulu, which is a specialist in everything related to tele-health.
Who is Dr. Arash Hakhamian from GGHTx program?
Dr. Arash Hakhamian is an important character in GGHTx, as he is the co-founder and medical director, specializing in dental surgery.
Dr. Arash is a lecturer and passionate about helping others, he has extensive experience as a volunteer, and his participation in establishing the GGHTx program has been invaluable as he has become a unique organization, exclusively for students or young professionals in the health, in which volunteers can travel the world helping others.
Dr. Arash's wish is that these incredible volunteer trips will soon resume, transforming people both doctors and patients, fluent in three languages English, Spanish and Persian.
Who is the co-founder Avi Kerendian of the GGHTx program?
Dr. Avi Kerendian, is a key player in the development of the GGHTx program, he is the co-founder, he is currently the director of the program. He holds a Biology degree, and had experience working at the Memorial Sloan Kettering Cancer Center (MSKCC), where he trained in multiple specialties.
He still has a tremendous passion for helping people, which has contributed to making the program a worldwide success. He also speaks several languages: English, Hebrew, Persian, and Spanish, all fluently.
Did the co-founders start the GGHTx and Dentulu alliances?
These great men in their tireless desire to help and contribute with other people began an alliance with Dentulu, which is a recognized company that specializes in tele-health, which is an idea that will revolutionize health care service in these countries of the Third World.
Thus reached the most remote places, and continuous monitoring of patients through technological resources that are available to everyone such as email, a mobile device, telephone or computer.
Studies have shown that chronic diseases can be treated remotely, the simple fact that the "Thank You" program Global Health Trip (GGHTx) makes available to the most vulnerable people in the world information to be treated, they can make a consultation to distance or diagnosing them is in itself an invaluable aid.
The short-term plan is to create a platform to continue supporting these low-income people or those who live in remote areas for free, as well as keep up with new technological trends, the world is rapidly moving to digital and the health branch cannot be left behind.
Avi Kerendian is the nonprofit co-founder and program director of GGHTx.
GGHTx is a global health non-profit. GGHTx brings together young volunteers. These are missions in changing lives through the power of global health. Together, GGHTx aids in intensive, week-long mission trips. In places like Latin America and Uganda. GGHTx fosters self-sufficiency. Avi Kerendian, co-founder of GGHTx, actively partners with local NGOs and Community-Based Organizations (CBOs). Avi Kerendian is passionate about contributing to the progress of global health, telehealth, and healthcare reform. Also, collaborating with others who are dedicated to making a difference. As co-founder of GGHTx, Avi Kerendian selected and help lead 45+ volunteers. These were five, week-long mission trips. Avi coordinated all logistical details from orientation to the setting up of medical sites. While there, Avi built alliances with locals. He fundraised and developed initiatives promoting health education. To date, GGHTx has delivered medical and dental relief to some 1,000 patients. 70% of whom are women and children. To learn more or get involved visit https://gghtx.org/. Or, reach out to Avi Kerendian here https://www.linkedin.com/in/avikerendian/
Post new comment
Please Register or Login to post new comment.